kras mutation and glutathion What should we know about the 'undruggable' target KRAS? KRAS Screening and Profiling Services
KRAS Screening and Profiling Services Research advances in the treatment of KRAS mutant colorectal cancer from Prof. Guoquan Gao's group at Zhongshan School of Medicine SUN YAT SEN UNIVERSITY Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis Cell Death & Disease Promising direction for the treatment of pancreatic cancers driven by KRAS mutation Der Lab
Pay in 4 interest-free payments of $5.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




